Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#6753
Rank
NZ$1.10 B
Marketcap
NZ$55.12
Share price
0.00%
Change (1 day)
0.58%
Change (1 year)

Financial Statements

Thumbnail Avalon Pharma (Middle East Pharmaceutical) Financial Statement 2023

Financial Statement 2023

Language: English

View Financial Statement